File S1 - Distinct Molecular Phenotypes in Male and Female Schizophrenia Patients

Table S1-Table S6. Table S1. Major depressive disorder (MDD) patient demographics. Table S2. Bipolar disorder (BPD) patient demographics. Table S3. List of 95 analytes measured using the HumanMAP® multiplex immunoassay platform and included in the comparison across all cohorts. Table S4. Summary of sex-specific changes in analyte levels within cohorts. Table S5. Summary of analyte levels with significant diagnosis-sex interactions in major depressive disorder (MDD). Table S6. Summary of analyte levels with significant diagnosis-sex interactions in bipolar disorder (BPD).
(DOC)